Observational Registry of Basal Insulin Treatment (ORBIT) in patients with type 2 diabetes uncontrolled with oral antihyperglycaemic drugs: Real-life use of basal insulin in China-Reference-Cited by-同舟云学术

Observational Registry of Basal Insulin Treatment (ORBIT) in patients with type 2 diabetes uncontrolled with oral antihyperglycaemic drugs: Real-life use of basal insulin in China

Published:2017-03-17 Issue:6 Volume:19 Page:822-830
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Ji Linong¹²,Zhang Puhong²,Zhu Dongshan²,Li Xian²,Ji Jiachao²,Lu Juming³,Guo Xiaohui⁴,Jia Weiping⁵,Weng Jianping⁶,Wu Yangfeng²,Yang Wenying⁷,Zou Dajin⁸,Zhou Zhiguang⁹,Pan Changyu³,Gao Yan⁴,Garg Satish K.¹⁰

Affiliation:

1. Department of Endocrinology and Metabolism; Peking University People's Hospital; Beijing China

2. The George Institute for Global Health at Peking University Health Science Center; Beijing China

3. Department of Endocrinology, Chinese PLA General Hospital; Beijing China

4. Department of Endocrinology, Peking University First Hospital; Beijing China

5. Department of Endocrinology and Metabolism, Shanghai Sixth Hospital; Shanghai China

6. Department of Endocrinology, The Third Affiliated Hospital of Sun Yat-sen University; Guangzhou China

7. Department of Endocrinology, China-Japan Friendship Hospital; Beijing China

8. Department of Endocrinology, The Second Military Medical University; Shanghai China

9. Department of Endocrinology and Metabolism, Xiangya Second Hospital; Changsha China

10. Barbara Davis Center for Diabetes; University of Colorado Denver; Denver Colorado

Funder

Sanofi-Aventis

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12886/fullpdf

Reference40 articles.

1. Prevalence and control of diabetes in Chinese adults;Xu;JAMA,2013

2. Trends in prevalence, awareness, treatment, and control of diabetes mellitus in mainland china from 1979 to 2012;Li;Int J Endocrinol,2013

3. Primacy of the 3B approach to control risk factors for cardiovascular disease in type 2 diabetes patients;Ji;Am J Med,2013

4. Psychological insulin resistance in type 2 diabetes patients regarding oral antidiabetes treatment, subcutaneous insulin injections, or inhaled insulin;Petrak;Diabetes Technol Ther,2013

5. Standards of care for type 2 diabetes in China;Weng;Diabetes Metab Res Rev,2016

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of insulin glargine 300 U/mL in people with type 2 diabetes in China: The INITIATION study;Diabetes, Obesity and Metabolism;2024-07-29

2. A Randomized Clinical Trial for Meal Bolus Decision Using Learning-based Control in Adults With Type 2 Diabetes;The Journal of Clinical Endocrinology & Metabolism;2024-03-07

3. Real-World Study on Effectiveness of Insulin Glargine U300 After Oral Antidiabetic Drug Failure in Patients with Type 2 Diabetes in the Gulf Region;Diabetes Therapy;2024-02-15

4. Effects of age and disease duration on the efficacy and safety of iGlarLixi in Asian people with type 2 diabetes: A post hoc analysis of the LixiLan‐O‐AP and LixiLan‐L‐CN trials;Diabetes, Obesity and Metabolism;2024-01-03

5. Efficacy and safety of adding once‐weekly dulaglutide to basal insulin for inadequately controlled type 2 diabetes in Chinese patients (AWARD‐CHN3): A randomized, double‐blind, placebo‐controlled, phase III trial;Diabetes, Obesity and Metabolism;2023-09-21